Cystatin C Testing Market

Cystatin C Testing Market Overview (2022 to 2032)

The global cystatin C testing market was valued at around USD 194.3 Million at the end of 2021. The market is projected to register a 7.5% CAGR and top a valuation of USD 400.4 Million by 2032.

Launch of various cystatin C testing kits and increasing prevalence of cystatin C-positive disorders among the population across the globe is expected to propel the cystatin C testing market growth.

Attributes	Details
Cystatin C Testing Market Value in 2021	USD 194.3 Million
Cystatin C Testing Market Value in 2032	USD 400.4 Million
Cystatin C Testing Market CAGR (2022 to 2032)	7.5%

The quantity of a protein, cystatin C in the blood is measured by the cystatin C test. Cystatin C is constantly created by the human body, and the protein is detected in several fluids, including spinal fluid, breast milk, and blood. The healthy kidneys sieve cystatin C from the blood so that it can be defecated in the urine.

What are the Major Drivers Boosting the Demand for Cystatin C Testing Market?

The increasing prevalence of several disorders such as myocardial infarction, and muscular dystrophy is one of the major factors that is accelerating the market growth. Besides this, the favorable reimbursement policies in the healthcare sector are a great advantage for cystatin C testing.

Furthermore, the growth in the number of pathology laboratories, hospital laboratories, research labs, and diagnostic centers across the geographies is boosting the market growth for the cystatin C testing market. Apart from this, the low cost of the reagents is also one of the major market stimulating factors. The increased investments in the healthcare sector by the government organizations of several nations are also expected to favor the cystatin C testing market.

Moreover, the major businesses in the market are highly investing in research and development activities, to offer novel and high-quality testing kits and products to the end users such as diagnostic laboratories, clinics, and hospitals. Besides this, the key market players are concentrating on activities like mergers and acquisitions. Due to these activities, the market is expected to grow at a rapid pace in the near future.

Which Region Shows Strong Growth Potential in the Cystatin C Testing Market?

North America held the largest share in the global cystatin C testing market and is expected to continue in the near future. The growing healthcare sector and the launch of novel products in the region are expected to accelerate the market during the forecast period. Europe is also estimated to witness lucrative growth over the projected period, owing to the advanced and developed healthcare facilities.

The increasing disposable income along with the rising health awareness, and increasing demand for diagnostic procedures especially in the geriatric population is the major factor that is expected to fuel the market growth in Asia Pacific Region.

Who are the Key Manufacturers in the Cystatin C Testing Market?

Some of the key manufacturers operating in the cystatin C testing market are Abbott, Eurolyser Diagnostica, Randox Laboratories, DiaSys Diagnostic Systems, Diazyme Laboratories, Tosoh India Pvt. Ltd., BBI Solutions, PerkinElmer, Siemens Healthcare Private Limited, and Pointe Scientific Inc.

Scope of Report

Report Attributes	Details
Growth Rate	CAGR of 7.5% 2022 to 2032
Base Year for Estimation	2021
Historical Data	2012 to 2021
Forecast Period	2022 to 2032
Qualitative Units	Revenue in USD Billion and CAGR from 2022 to 2032
Report Coverage	Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis
Segment Covered	Product, Test, Application, End User, Region
Region Covered	North America; Latin America; Europe; East Asia; South Asia; Oceania; Middle East Africa
Key Countries Profiled	USA, Canada, Brazil, Mexico, Germany, UK, France,Spain, Italy, China, Japan, South Korea, Malaysia, Singapore, Australia, New Zealand, GCC, South Africa, Israel
Key Players	Abbott; Eurolyser Diagnostica; Randox Laboratories; DiaSys Diagnostic Systems; Diazyme Laboratories; Tosoh India Pvt. Ltd.; BBI Solutions; PerkinElmer; Siemens Healthcare Private Limited; Pointe Scientific Inc.
Customization	Available Upon Request

Table of Content

• 1. Executive Summary
• 2. Industry Introduction, including Taxonomy and Market Definition
• 3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments
• 4. Global Market Demand Analysis and Forecast, including Historical Analysis and Future Projections
• 5. Pricing Analysis
• 6. Global Market Analysis and Forecast
  • 6.1. Product
  • 6.2. Test
  • 6.3. Application
  • 6.4. End User
• 7. Global Market Analysis and Forecast, By Product
  • 7.1. Instruments
  • 7.2. Reagents
  • 7.3. Kits
• 8. Global Market Analysis and Forecast, By Test
  • 8.1. Colorimetric Assay Based Tests
  • 8.2. Enzymatic Tests
  • 8.3. Point of Care Tests
  • 8.4. ELISA Based Tests
  • 8.5. Others
• 9. Global Market Analysis and Forecast, By Application
  • 9.1. Research and Development
  • 9.2. Diagnosis Use
• 10. Global Market Analysis and Forecast, By End User
  • 10.1. Hospitals
  • 10.2. Clinics
  • 10.3. Diagnostic Laboratories
  • 10.4. Renal Care Centers
  • 10.5. Academic Research Institutes
• 11. Global Market Analysis and Forecast, By Region
  • 11.1. North America
  • 11.2. Latin America
  • 11.3. Europe
  • 11.4. East Asia
  • 11.5. South Asia & Pacific
  • 11.6. The Middle East and Africa (MEA)
• 12. North America Sales Analysis and Forecast, by Key Segments and Countries
• 13. Latin America Sales Analysis and Forecast, by Key Segments and Countries
• 14. Europe Sales Analysis and Forecast, by Key Segments and Countries
• 15. East Asia Sales Analysis and Forecast, by Key Segments and Countries
• 16. South Asia & Pacific Sales Analysis and Forecast, by Key Segments and Countries
• 17. The Middle East and Africa (MEA) Sales Analysis and Forecast, by Key Segments and Countries
• 18. Sales Forecast by Product, Test, Application, and End User for 30 Countries
• 19. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard
• 20. Company Profile
  • 20.1. Eurolyser Diagnostica
  • 20.2. Randox Laboratories
  • 20.3. DiaSys Diagnostic Systems
  • 20.4. Diazyme Laboratories
  • 20.5. Tosoh India Pvt. Ltd.
  • 20.6. BBI Solutions
  • 20.7. PerkinElmer
  • 20.8. Siemens Healthcare Private Limited
  • 20.9. Pointe Scientific Inc.